Gordon McLennan, M.D. FSIR, has been practicing interventional radiology us since 2000. After completing his fellowship at Indiana University, he remained on faculty as director of Interventional Radiology research for eight years where he focused on the biology of dialysis access failure and liver cancer biology.  He moved his laboratory from Indiana to the Cleveland Clinic in 2008 where he was Professor of Radiology & Biomedical Engineering with a primary research focus on finding materials for sustained drug delivery and understanding of the tumor microenvironment associated with the hepato-cellular cancer to develop more specific targeted pharmaceuticals for the treatment of liver cancer.  While at the Cleveland Clinic, he developed a multidisciplinary program with Vascular Surgery & Nephrology for the implementation of Endo AVF creation in inpatients who receive tunneled catheters as primary access. He has had a continuing commitment to the dialysis access community through his service as Chair of the Society of Interventional Radiology Genitourinary & Dialysis subspecialty council and on the board of trustees of the Renal Network, Inc., a quality assurance organization for dialysis access care, for 11 years. Over the course of his career, Dr. McLennan has received over $3,000,000 in extramural funding and has published 71 peer reviewed articles, 113 abstracts, and presented over 50 invited lectures. He has served the Interventional Radiology community as Chairman of the Society of Interventional Radiology Foundation where he helped raise $6.5 Million to support Interventional Radiology research and he was the recipient of the SIR foundation Philanthropist of the year award in 2016.